Regulation of Glucose, Lipid, and Amino Acid Metabolism in Normal Healthy Subjects. //New aspects of Clinical Nutrition. – Karger, Basel – 1983.-pp. 169–210.
Gaddi ACiarocchi A., Matteucci A. et al. Dietary treatment for familal hypercholesterolemia – differential effects of dietary soy protein according to the apolipoprotein E phenotypes//Amer. J. Clin. Nutr. -1991. – V. 53. – P. 1191– 1196.
Golden М. H. N.JacksonA.A. «Chronic Severe Undernutrition» in Olson R.E. (ed.) «Present Knowlidge of Nutrition» Washington, D.C. Nutrition Foundation, Inc. 1984. – P. 57.
Goldstein D.J. Assesment of nutritional status in Renal Disease//Handbook of nutrition and the kidney/Eds. W. E. Mitch, S. Klarh. – Philadelphia. New-York: Lepincott Raven. – 1998. – P. 45– 86.
GretzN., LasserreJ.J.,JerableA., StrauchM. Protein/Aminoacid composition of low-proteindiet//Contr. to Nephrol. – 1989.– V. 72. P. 11–20.
Guameri G., Toido G., Situlin R. et al. The assesment of nutritional status in chronically uremic patient/Low protein diet in renal patients/ Ed. N. Gretz, S. Giovannetti, M. Strauch/Contr. Nephrol. – 1989. – V. 72. – P. 73– 103.
Ids J. VDaly J. М., Evantash E. et al. Immunomodulatory mechanisms of arginine//Surgery. – 1988. – V. 104, N. 2. – P. 142–151.
Ikizler T. AGreene Т., Schluchter M. D. et al. Spontaneous dietary protein intake during progression of chronical renal failure//!. Amer. Soc. Nephrol. – 1995. -V. 6, N. 5.-P. 1386–1391.
Ikizler T. AHakim R. M. Nutrition in end-stage renal disease//Kidney Int. – 1996 – V. 50, N. 2 – P. 343– 357.
Jayo-Rao K. S. Evolution of kvashiorkor and marasmus//Lancet. – 1975. – V.1254, i. – P. 709–711.
Harsanyi L., Allison S. PBerger M.M. Nutritional support in burn patients/ Basics in clinical nutrition. – ESPEN: Galen, 2002. – P. 234–239.
HartyJ. C.y Boulton H., CurwellJ. et al. The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients//Kidney Int. – 1994. – V. 45, N. 1. -P. 103–109.
Heymsfield S. ВMcMoney C., Stevens VSmith J. Muscle mass: reliable of energy malnutrition severity and outcome // Am. J. Clin. Nutr. – 1982. – V.35, N. 5. – P.1192–1199.
Hof man T. IgE and IgG antibodies in children with food allergy. – Rocz. Akad. Med. Bialymst. – 1995. – 468-73.
Hsieh C. Y., Santell R. C., Haslam S. Z., Helferich W. G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo//Cancer Res. – 1998. – V. 58, N. 17. – P. 3833–3838.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS-33). UK Prospective Diabetes Study Group. Lancet 1998 – 352–837– 53.
Howard R. ВHerbold N. H. Nutrition in Clinical Care. – New York, 1982.– 776p.
Kelley D. E. Effects of weight loss on glucose homeostasis inNIDDM. Diabetes Rev. – 1995. – V. 3. – P. 366–377.
Kinney J. М., Weissman C. Forms of malnutrition in stressed and unstressed patient//Clinics in chest medicine. – V.7, N.l – 1986. – P. 19–28.
Klimt C. R., Knatterud G. L., Meinert C. L., Prout Т. E. A study of the effect of hypoglycemic agents on vascular complications in patients with adult-onset diabetes.
I. Design, methods and baseline characteristics. The University Group Diabetes Program. Diabetes 1970. – 19 Suppl. – P. 747—88.
Koople J. D. The nutrition managment of the patient with acute renal failure/ /JPEN. – 1995. – V. 20, N.I. – P. 109–114.
KoopleJ. D. Nutrition managment of nondialyzed patients with cronical renal failure//Nutrition managment of renal disease/Koople J. D., Massry S. G. – Baltimore: Williams-Willkins, 1997. – P. 479– 530.
Krichevsky D., Tepper S. ACzameski S. K. et al. Experimental atherosclerosis in rabbits fed cholesterol-free diets, part 9 beef protein and textured vegetable protein// Atherosclerosis. – 1981. – V. 39. – P. 169–175.
Levin R. G. Assesing small intestinal function in health and disease // Scand. G. Gastroenterology. – 1982. – V. 17. Suppl. 74 – P. 1– 5.
Lindholm K., Bergstrom J. Nutritional requirments of peritoneal dialysis patient/ The Textbook of peritoneal dyalisis/R. Gokal, K. D. Nolf, Klewer Academ.Publish. Dordrecht, Boston, London: 1994. – P. 443–472.
Linsday R. М., SpanerE., Heidenheim R. P. et al. Which come first, KT/V or PCR – chicken or egg?//Kidney Int. – 1992. – V.42, Suppl.38. – P. 32– 36.
Lo G. S., Goldberg A. P., LimA. et al. Soy fiber improves lipid and carbohydrate methabolism in primary hyperlipidemic subjects/Atherosclerosis. – 1986. – V. 62. -P. 239– 248.
Lo G. S.,Cole T. G. Soy cotelydon fiber prodacts reduce plasma lipids// Atherosclerosis. – 1990. – V. 82. – P. 59–67.
Lowrie E. G., Lew N. L. Death risk in hemodialysis patients. The predictive value of commonly measured variables and an evaluation of death rate differences between facilities//Amer. J. Kidney Dis. – 1990. – V. 15, N. 5. – P. 458– 482.
Lucarelli, S., Frediani T. et al. (Specific IgG and IgA antibodies and related sub-classes in the diagnosis of gastrointestinal disorders or atopic dermatitis due to cow’s milk and egg, International Journal of Immunopathology and Pharmacology. – 1998.—V. 11, T. 2. – P. 77– 85.
Mahan L.K., Escott-Stump S. Krause’s food, nutrition and diet therapy. - Philadelphia: Saunders, 2004. – 1321 p.
Marinkovich V. Specific IgG antibodies as markers of adverse reactions to foods // Monogr. Allergy. – 1996.-V. 32. – P. 221– 225.
Me Laren D. S. A fresh look at antropometric classification schemes in protein-energy malnutrition// Antropometric assessment of nutritional status /Eds. J. H. Himes. – New York. Willey-Liss. – 1991. – P. 273–286.
McWhirterJ. P., Pennington C. R. Incidence and recognition of malnutrition in hospital//BMJ. – 1994. – V. 308, N. 9. – P. 945– 948.
Meinert C.L ., Knatterud G.L., Prout T.E., Klimt C.R. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970; 19 Suppl:789–830.
Melchior J. – C. Diagnostic et depistage de la denutrition// La revue du praticien, 2003.-P. 3–7.
Modern nutrition in health and disease/Eds. by М. E. Shils, J. A. Olson, M. Shike., 8th ed. – Baltimore, Philadelphia: Williams and Williams, 1994. – 1657 p.
MullenJ. L. et al. Reduction of operative morbidity and mortality by combined preoperative and postoperative nutritional support // Ann. Surg. – 1980. – Vol. 192, N 5.-P. 604–613.
Nagata C., Kabuto М., Kurisu Y., Shimizu H. Decreased serum estradiol concentration associated with high die-tary intake of soy products in premenopausal Japanese women//Nutr. Cancer. – 1997. – V. 29, N. 3. – P. 228–233.
National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults// Circulation.– 1994.-N. 89.-P. 1329–1445.
Obesity. The Report of the British Nutrition Foundation Task Force. – London. – UK. – Blackwell Science. – 258 p.
Obesity. Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. – Geneva, 3–5 June 1997. – 276 p.
Ornish D. Dr. Dean Ornishrs Program for Reversing Heat Disease. New York, Ballantine Books, 1995.
Ornish D., Shirley E. Brawn et al. Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial//Lancet. – 1990. – V. 336. – P. 129– 133.
PawingH. Ft., GallM.A., Skott MA. Jorgensen H.E., LokkegaardH.Jorgensen.
F. et al. Prevalence and causes of albuminuria in non-insulin- dependent diabetic patients. Kidney Int. – 1992.—V. 41. – P. 758–762.
Pedersen T. R. et al. Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin survival study. // Circulation. – 1996. – N93 (10).-P. 1796–1802.
PotterS. M. Soy protein and serum lipids. // Curr. Opin. Lipidol. – 1996. – V. 7, N. 4.-P. 260– 264.
PotterS. М., PertileJ. Soy protein concentrate and isolated soy protein similarly lower blood serum cholesterol but differently affect thyroid hormones in hamsters// J. Nutr. – 1996. – V. 126, N. 8. – P. 2007–2011.
Preventing and Managing the Global Epidemic of Obesity. Report of the Would Organization of Obesity. WHO, Geneva, – 1997 r.
Protein Reference Values in the Russion Federation. WHO, Regional office for Europe Nutrition unit – WHO – 1992.
Prochaska G. O., DiClemente С. C. Towards a comprehensive model of change./ in: Miller W.A., Heather N. (Eds). Treating addictive behaviors. Processes of change. – New York. – Plenum. – 1986.
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian simvastatin survival study (4S)//Lancet.– 1994. – V. 344 (8934).-P. 1383–1389.
Record I. R., Broadbent J. L., King R. A. et al. Genistein inhibits growth of В16 melanoma cells in vivo and in vitro and promotes differentiation in vitro//Int. J. Cancer. – 1997. – V. 72., N. 5. – P. 860–864.
Reddy V. Protein- energy malnutrition; an overview/ Nutrition in health and disease and industrial development/Eds. A. E. Harper, G.
